Clinical Trial Update: Biomarkers Investigation of Neoadjuvant Chemotherapy for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 biomarker investigation study of neoadjuvant chemotherapy for breast cancer; the current trial status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN